A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509488-26-00

Acronym

22375

Enrollment

Registered

2024-05-31

Start date

2024-07-18

Completion date

2024-08-20

Last updated

2024-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack in combination with antiplatelet therapy

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Countries

Germany

Outcome results